FRUQUINTINIB
Clinical trials for FRUQUINTINIB explained in plain language.
Never miss a new study
Get alerted when new FRUQUINTINIB trials appear
Sign up with your email to follow new studies for FRUQUINTINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo aims to wipe out hidden cancer cells after chemo
Disease control Recruiting nowThis study tests whether two drugs, fruquintinib and tislelizumab, can control colorectal cancer in people who still have signs of cancer cells in their blood after finishing chemotherapy. About 20 adults with stable disease will receive the combination to see if it is safe and c…
Matched conditions: FRUQUINTINIB
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 09:19 UTC
-
New hope for colorectal cancer: chemo-free combo targets tumors without harsh side effects
Disease control Recruiting nowThis study tests whether a combination of two targeted drugs (cetuximab beta and fruquintinib) with or without immunotherapy can control advanced colorectal cancer without traditional chemotherapy. About 70 adults with a specific genetic type (RAS/BRAF wild-type) will receive the…
Matched conditions: FRUQUINTINIB
Phase: PHASE2 • Sponsor: Zhejiang University • Aim: Disease control
Last updated May 26, 2026 09:00 UTC
-
New drug cocktail shows promise for tough stomach cancer
Disease control Recruiting nowThis study is testing whether adding a drug called fruquintinib to standard chemotherapy and trastuzumab can help control advanced HER2-positive stomach or gastroesophageal junction cancer. It is for people who have not had prior treatment for their metastatic disease. The goal i…
Matched conditions: FRUQUINTINIB
Phase: PHASE1, PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated May 18, 2026 12:11 UTC